GTN uses machine learning and quantum physics technology to simulate, analyse and discover chemicals computationally.
CEO Noor Shaker was an assistant professor at Aalborg University, Copenhagen and worked on machine learning. Shaker and GTN were named in the top 100 AI Leaders in Drug and Discovery and Advanced Healthcare by Deep Knowledge Analytics in 2019. In 2018 she was listed at one of the top 30 women leaders in UK healthcare.